282 related articles for article (PubMed ID: 24579249)
41. Local and systemic therapies for malignant pleural mesothelioma.
Gomez D; Tsao AS
Curr Treat Options Oncol; 2014 Dec; 15(4):683-99. PubMed ID: 25266654
[TBL] [Abstract][Full Text] [Related]
42. Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.
Friedberg JS; Simone CB; Culligan MJ; Barsky AR; Doucette A; McNulty S; Hahn SM; Alley E; Sterman DH; Glatstein E; Cengel KA
Ann Thorac Surg; 2017 Mar; 103(3):912-919. PubMed ID: 27825687
[TBL] [Abstract][Full Text] [Related]
43. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.
Baldini EH; Richards WG; Gill RR; Goodman BM; Winfrey OK; Eisen HM; Mak RH; Chen AB; Kozono DE; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2015 May; 149(5):1374-81. PubMed ID: 25772281
[TBL] [Abstract][Full Text] [Related]
44. Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study.
Spaggiari L; Marulli G; Bovolato P; Alloisio M; Pagan V; Oliaro A; Ratto GB; Facciolo F; Sacco R; Brambilla D; Maisonneuve P; Mucilli F; Alessandrini G; Leoncini G; Ruffini E; Fontana P; Infante M; Pariscenti GL; Casiraghi M; Rea F
Ann Thorac Surg; 2014 Jun; 97(6):1859-65. PubMed ID: 24726598
[TBL] [Abstract][Full Text] [Related]
45. Pleural mesothelioma: tackling a deadly cancer.
The Lancet Respiratory Medicine
Lancet Respir Med; 2019 Feb; 7(2):99. PubMed ID: 30660508
[No Abstract] [Full Text] [Related]
46. Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review.
Miller AC; Miettinen M; Schrump DS; Hassan R
Ann Am Thorac Soc; 2014 Sep; 11(7):1075-81. PubMed ID: 25079105
[TBL] [Abstract][Full Text] [Related]
47. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
[TBL] [Abstract][Full Text] [Related]
48. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
[TBL] [Abstract][Full Text] [Related]
49. The timing of chemotherapy in the management plan for medically operable early-stage malignant pleural mesothelioma.
Shohdy K; Abdel-Rahman O
Expert Rev Respir Med; 2019 Jun; 13(6):579-584. PubMed ID: 30977408
[No Abstract] [Full Text] [Related]
50. How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
Sharkey AJ; O'Byrne KJ; Nakas A; Tenconi S; Fennell DA; Waller DA
Lung Cancer; 2016 Oct; 100():5-13. PubMed ID: 27597274
[TBL] [Abstract][Full Text] [Related]
51. A catalogue of treatment and technologies for malignant pleural mesothelioma.
Schunselaar LM; Quispel-Janssen JM; Neefjes JJ; Baas P
Expert Rev Anticancer Ther; 2016; 16(4):455-63. PubMed ID: 26943000
[TBL] [Abstract][Full Text] [Related]
52. The recurrence of malignant pleural mesothelioma 14 years after extrapleural pneumonectomy: possible histological transformation.
Kinoshita T; Ishii G; Matsumura Y; Shiozawa T; Aokage K; Hishida T; Yoshida J; Nagai K
Pathol Int; 2012 Nov; 62(11):754-7. PubMed ID: 23121607
[TBL] [Abstract][Full Text] [Related]
53. Use of cancer therapy at the end of life in patients with malignant pleural mesothelioma.
Kao SC; van Zandwijk N; Corte P; Clarke C; Clarke S; Vardy J
Support Care Cancer; 2013 Jul; 21(7):1879-84. PubMed ID: 23408016
[TBL] [Abstract][Full Text] [Related]
54. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
Cao C; Tian D; Park J; Allan J; Pataky KA; Yan TD
Lung Cancer; 2014 Feb; 83(2):240-5. PubMed ID: 24360321
[TBL] [Abstract][Full Text] [Related]
55. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
[TBL] [Abstract][Full Text] [Related]
56. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Kindler HL; Ismaila N; Armato SG; Bueno R; Hesdorffer M; Jahan T; Jones CM; Miettinen M; Pass H; Rimner A; Rusch V; Sterman D; Thomas A; Hassan R
J Clin Oncol; 2018 May; 36(13):1343-1373. PubMed ID: 29346042
[TBL] [Abstract][Full Text] [Related]
57. Optimal surgery for resectable malignant pleural mesothelioma in the setting of multimodality treatment.
Kondo N; Hasegawa S
Surg Today; 2024 Jul; 54(7):663-669. PubMed ID: 37474704
[TBL] [Abstract][Full Text] [Related]
58. An unusual presentation of malignant pleural mesothelioma.
Lacle MM; van Oosterhout MF
J Thorac Oncol; 2013 Jul; 8(7):e63-4. PubMed ID: 23774388
[No Abstract] [Full Text] [Related]
59. Multimodal treatment for malignant pleural mesothelioma.
Rintoul RC; Treasure T; Macbeth F
Lancet Oncol; 2015 Dec; 16(16):1576-7. PubMed ID: 26538424
[No Abstract] [Full Text] [Related]
60. Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.
Takuwa T; Hashimoto M; Matsumoto S; Kondo N; Kuribayash K; Nakano T; Hasegawa S
Int J Clin Oncol; 2017 Oct; 22(5):857-864. PubMed ID: 28439676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
